Related Experiment Videos
Clinical issues in shared decision-making applied to breast cancer
Nora Moumjid1, Marie-Odile Carrère, Marie Charavel
1GRESAC UMR 5823 CNRS, Centre Léon Bérard, Lyon, France.
Summary
This pilot study found shared decision-making feasible in breast cancer treatment, with most patients satisfied with participation despite initial anxiety. Further research is needed to confirm benefits and patient willingness.
Area of Science:
- Oncology
- Health Services Research
- Patient-Centered Care
Background:
- Shared decision-making (SDM) is crucial in oncology, particularly for breast cancer treatment choices.
- Patient involvement in treatment decisions can significantly impact outcomes and satisfaction.
- Understanding patient preferences for decision-making is essential for effective clinical practice.
Purpose of the Study:
- To evaluate clinical issues during medical encounters for breast cancer.
- To assess the feasibility of implementing shared decision-making in practice.
- To explore patients' preferences regarding who should decide on breast cancer treatments.
Main Methods:
- A qualitative pilot study was conducted at a comprehensive cancer center.
- Decision boards and information booklets were used during clinical encounters.
- Patient reactions and the practical feasibility (consultation duration) of SDM were analyzed.
Main Results:
- Most patients participated in decisions regarding surgery (all chose conservative treatment) and chemotherapy.
- While some patients experienced anxiety and uncertainty, most were satisfied with the information and participation.
- The duration of SDM consultations was found to be consistent with standard practice for severe diseases.
Conclusions:
- Shared decision-making appears feasible in breast cancer care, despite being uncommon in France.
- Patient satisfaction with participation suggests potential benefits.
- A larger quantitative study is recommended to confirm feasibility, patient willingness, and benefits of SDM.